FDA Updates Comparative Performance Data to Include Most Available SARS-CoV-2 Diagnostic Tests
![FDA maze of regulations](https://covid19briefings.com/wp-content/uploads/2020/05/AS_301344926-FDA-Blue-Maze-sm-1024x576.jpeg)
New FDA update to comparative COVID-19 test performance data now includes information about most available SARS-CoV-2 diagnostic molecular tests.
Clinical Laboratory Supply Shortages Are Beginning to Affect More Than Just COVID-19 Testing
![FDA updates direction on alternative COVID-19 testing supplies](https://covid19briefings.com/wp-content/uploads/2020/06/AS_255771503-lab-test-supply-substitution-graphic-flat.jpg)
Some 122 clinical laboratories reveal how supply shortages extend beyond COVID-19 testing supplies.